Met Life Investment Management, LLC Celldex Therapeutics, Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 37,332 shares of CLDX stock, worth $887,754. This represents 0.01% of its overall portfolio holdings.
Number of Shares
37,332
Previous 37,332
-0.0%
Holding current value
$887,754
Previous $1.38 Million
8.18%
% of portfolio
0.01%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding CLDX
# of Institutions
203Shares Held
67.3MCall Options Held
1.69MPut Options Held
980K-
Wellington Management Group LLP Boston, MA9.24MShares$220 Million0.06% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$112 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.87MShares$92 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.46MShares$82.2 Million9.64% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$79.2 Million1.99% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.11B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...